Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Chiron_Corporation
|
| gptkbp:acquired |
gptkb:Novartis
|
| gptkbp:clinical_trial |
various vaccine candidates
|
| gptkbp:dissolved |
gptkb:2006
|
| gptkbp:founded |
gptkb:1993
|
| gptkbp:founder |
gptkb:Dr._William_Haseltine
|
| gptkbp:headquarters |
gptkb:Emeryville,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Chiron Vaccines
|
| gptkbp:industry |
gptkb:drug
|
| gptkbp:key_people |
gptkb:Dr._William_Haseltine
gptkb:David_A._Kessler gptkb:Dr._John_C._Martin |
| gptkbp:market |
global
|
| gptkbp:notable_products |
gptkb:Hepatitis_B_vaccine
Influenza vaccine |
| gptkbp:partnership |
gptkb:U._S._government
various universities other biotech companies |
| gptkbp:products |
vaccines
|
| gptkbp:regulatory_compliance |
gptkb:FDA
gptkb:EMA |
| gptkbp:research_focus |
infectious diseases
biodefense |
| gptkbp:revenue |
$1 billion (peak)
|
| gptkbp:successor |
gptkb:Novartis_Vaccines_and_Diagnostics
|